International Society of Liquid Biopsy – ISLB shared a post on X:
“Liquid Biopsy in Breast Cancer SABCS2025 highlights
Liquid biopsy is increasingly shaping breast cancer care across the entire disease continuum.
- ctDNA, CTCs, immune profiling and proteomics moving into clinical use
- Better risk stratification and more informed treatment decisions
- Deeper insight into tumor biology and evolution
- New opportunities for early intervention and survivorship care
As evidence grows, liquid biopsy is becoming a core component of precision oncology in breast cancer.”
Title: Cancer in a drop: Liquid biopsy highlights from the San Antonio Breast Cancer Symposium (SABCS) 2025
Authors: Eleonora Nicolò, Konstantinos Venetis, Enes Erul, Pasquale Pisapia, Letizia Pontolillo, Carolina Reduzzi
Read the Full Article on JLB
More posts about ISLB.
